• Budget Impact of the Introduction of Subcutaneous Rituximab to U.S. Health Plans

    May 1, 2018, 00:00

  • Evaluation of Cost of Hospitalizations Related to Nausea and Vomiting Among Cancer Patients

    May 1, 2018, 00:00

  • Medium Term Tendency of Annual Direct Medical Cost of Pediatric Pulmonary Hypertension Health Care in Centro Medico Nacional 20 De Noviembre (Nmcissste, Mexico)

    May 1, 2018, 00:00

  • Burden of Hospitalization In Lung Cancer Patients with Brain Metastases- Analysis Of US National in-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • How Patient Organizations are Using Patient-Reported Outcomes- Survey Results from a Non-Probability Sample of Patients Count Network Members

    May 1, 2018, 00:00

  • Prevalence, Disease Burden and Unmet Needs of Patients With Essential Tremor- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Prospective Evaluation of Anterior Cruciate Ligament Reconstruction Outcomes with the Knee Injury and Osteoarthritis Score (Koos)

    May 1, 2018, 00:00

  • Pharmaceutical Expenditures, out of Pocket Costs, and Impact of Provider Factors- Intersection of Health Economics and the Marketing Mix

    May 1, 2018, 00:00

  • Development and Validation of a Model to Predict Cessation of Antihyperglycemic Medication after Laparoscopic Bariatric Surgery Among Patients with Type 2 Diabetes

    May 1, 2018, 00:00

  • Policies and Processes Applicable to Drugs for Very Rare Diseases in Australia, Canada, England, France and Germany

    May 1, 2018, 00:00

  • Interpretation of Change In Patient-Reported Outcomes in Treatment-Resistant Depression

    May 1, 2018, 00:00

  • Effect of Core Stability Training Program Among Ice Hockey Players

    May 1, 2018, 00:00

  • Benefits of a Heart-Shaped Suturing Technique in Cesarotomy Closure- Experience from an Academic Medical Center in China

    May 1, 2018, 00:00

  • Impact of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Utilization and Healthcare Costs Among Individuals with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00

  • Linguistic Validation of the Endometriosis Treatment Satisfaction Questionnaire (ETSQ) in 3 Languages for Endometriosis Patients

    May 1, 2018, 00:00

  • Reimbursement of Medicines in Ukraine- Issues and Challenges

    May 1, 2018, 00:00

  • Effects of Canagliflozin on Cardiovascular Outcomes and All Cause Mortality- A Review And Meta-Analysis

    May 1, 2018, 00:00

  • Methods for Reporting the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Data in Cancer Clinical Trials

    May 1, 2018, 00:00

  • Treatment Pattern And Direct Medical Costs Among Patients With Lung Cancer In China

    May 1, 2018, 00:00

  • Evaluating Different Indirect Treatment Comparison Approaches- A Case Study in Acute Myeloid Leukemia Patients Ineligible to Receive Intensive Chemotherapy

    May 1, 2018, 00:00

  • Cost-Effectiveness of a Twin Interlocking Derotation and Compression Screw Cephalomedullary Nail (2-Screw Nail)* with a Single Screw Derotation Cephalomedullary Nail (Single-Screw Nail)** in Patients with Intertrochanteric HIP Fractures

    May 1, 2018, 00:00

  • Trends in Baseline Retinal Examinations and Associated Factors Among New Initiators of Hydroxychloroquine in Medicare- 2011-2015

    May 1, 2018, 00:00

  • Evaluation of Adherence and its Predictors Among Persons of Ethiopian Descent in Washington DC

    May 1, 2018, 00:00

  • Respiratory Illness (RI) and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH) in Infants with Congenital Diaphragmatic Hernia (CDH) in the Caress Registry (2005-2017)

    May 1, 2018, 00:00

  • Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period

    May 1, 2018, 00:00

  • A Review of the International New Drug Landscape

    May 1, 2018, 00:00

  • Utilizing the 3S Framework to Understand the Patient’s Preference when Addressing Non-Adherence in Patients with Diabetes

    May 1, 2018, 00:00

  • A Qualitative Study to Explore the Content Validity of Patient-Reported Outcome Measures in a Systemic Lupus Erythematosus Population

    May 1, 2018, 00:00

  • Cost Estimates of Human Immunodeficiency Virus (HIV) Disease Management in the United States - A Literature Review

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma

    May 1, 2018, 00:00

  • Comparison of Structured Versus Abstracted Comorbidities Using Oncology EHR Data from Cancer Patients in the Flatiron Health Network

    May 1, 2018, 00:00

  • Impact of the Affordable Care Act (ACA)’S Elimination of Cost-Sharing Provision on the Guideline-Recommended Cancer Preventive Screenings in the United States

    May 1, 2018, 00:00

  • Low Birth Weight in Newborns and Associated Maternal and Neonatal Factors in a Colombian Gineco-Obstetrical Hospital

    May 1, 2018, 00:00

  • Economic Burden of Infant-Onset (Type 1) Spinal Muscular Atrophy- A Retrospective Claims Database Analysis

    May 1, 2018, 00:00

  • Long-Term Epidemiological Impact of Pertuzumab+Trastuzmab on Metastatic Breast Cancer Incidence in Canada

    May 1, 2018, 00:00

  • Cost-Effectiveness of Breast Cancer Screening Program in the Republic of Kazakhstan

    May 1, 2018, 00:00

  • What’s the Burden of Burden of Illness Reviews?

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Intraabdominal Infection

    May 1, 2018, 00:00

  • Improved Outcomes and Neutral Hospital Budget Impact Associated with Flowable Gelatin for Lumbar Surgery in a Chinese Tertiary Care Hospital- A Retrospective Case-Series Study

    May 1, 2018, 00:00

  • Challenges in Research and Health Technology Assessment of Rare Disease Technologies- Report of the ISPOR Rare Disease Special Interest Group

    May 1, 2018, 00:00

  • Dose-Response Association Between Concurrent Opioid and Benzodiazepine use and Risk of Opioid- Related Overdose

    May 1, 2018, 00:00

  • Modeling the Public Health Impact of Varicella Vaccination in Argentina- Implications of Vaccine Choice and Dosing Schedules

    May 1, 2018, 00:00

  • Psychometric Analyses of Pros in Bronchiectasis

    May 1, 2018, 00:00

  • Retrospective Validation of Predicted Long-Term Survival Estimates from an Early Data Cut of the Phase III Checkmate 025 Study in Advanced Renal Cell Carcinoma

    May 1, 2018, 00:00

  • Modeling the Reduction in the Clinical Burden of Migraine with Erenumab Treatment

    May 1, 2018, 00:00

  • Predictors and Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • A Naturalistic Observation Study of Current Medication Counseling Practices at Retail Chain Pharmacies in the Houston Area

    May 1, 2018, 00:00

  • Surgical Procedures for Knee Osteoarthritis- Volume and Costs Among the Commercially-Insured Patients in the United States

    May 1, 2018, 00:00

  • Assessment of Anticholinergic Burden scales and Measures for Estimating Anticholinergic Exposure in Retrospective u.s. Database Analyses

    May 1, 2018, 00:00

  • Shift in the Status Quo- How Biosimilar Interchangeability Can Lead to Significant Cost Savings

    May 1, 2018, 00:00

  • Cost-Utility Analysis of two Ultrasound-Guided Breast Biopsies- Vacuum-Assisted Biopsy Versus Conventional Core Needle Biopsy

    May 1, 2018, 00:00

  • New Structured Search Method that Allows Identify and Map Potential Patients with Cystic Fibrosis Not Yet Diagnosed

    May 1, 2018, 00:00

  • Cost Effectiveness of Ultra-Violet Germicidal Irradiation in Canadian Health Region

    May 1, 2018, 00:00

  • A 2-Arm Randomized Pilot Study To Evaluate The Impact Of A Mobile Health Application On Medication Adherence In Patients On Oral Anti-Cancer Medications

    May 1, 2018, 00:00

  • Merging of the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support (PediMACS) with an Exyernal Administrative Database Using Indirect Patient Identifiers to Develop a More Comprehensive Platform for Health Economics ...

    May 1, 2018, 00:00

  • Assessment of the Burden of Multiple Sclerosis On Family Caregivers By Patient Disability Severity

    May 1, 2018, 00:00

  • Colorectal Cancer Screening Pilot Program Results In Hungary

    May 1, 2018, 00:00

  • Cost-of-Illness and Treatment Patterns of Gynecologic Cancer in the United States- An Empirical Analysis Based On MEPS Database 2007-2014

    May 1, 2018, 00:00

  • Association Between Recombinant Tissue Plasminogen Activator and In-Hospital Mortality/30-Day Readmission Among Mechanical Thrombectomy Patients- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Evaluation of Subcutaneous Rituximab Administration Impacts on Canadian Systemic Therapy Suites

    May 1, 2018, 00:00

  • Linkage Between Orthopedic Registry and Administrative Data Using Indirect Identifiers for National Device Infrastructure Development

    May 1, 2018, 00:00

  • Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

    May 1, 2018, 00:00

  • Long-Term Health Benefit of Ibalizumab In The Treatment of Adults with Multidrug-Resistant HIV-1 Infection

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Urinary Tract Infections

    May 1, 2018, 00:00

  • A Method to Use Administrative Claims to Categorize Dementia Cases by Subtype

    May 1, 2018, 00:00

  • Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib

    May 1, 2018, 00:00

  • Real-World Analysis of Treatment Patterns and Long-Term Effectiveness Among Patients with Advanced Neuroendocrine Tumors of Lung Origin (Lung Net)- A Multicenter Study

    May 1, 2018, 00:00

  • Predictors of All-Cause Healthcare Payments Among Patients With Treatment-Resistant Major Depressive Disorder

    May 1, 2018, 00:00

  • The Impact of Online Patient Communities on Patient Outcomes- A Systematic Review

    May 1, 2018, 00:00

  • The Problem of Rarity- Estimation of Prevalence in Rare Disease

    May 1, 2018, 00:00

  • Perception of Students in Health Professions Towards Influenza Vaccination- A Web-Survey at a Private Midwestern University

    May 1, 2018, 00:00

  • Trends in Approval of Therapeutic Biologic Approved by the US Food and Drug Administration (1986–2017)

    May 1, 2018, 00:00

  • Once Daily Vibegron Improves Quality of Life Measures in Patients with Overactive Bladder

    May 1, 2018, 00:00

  • FDA Orphan Exploitation? Are Pharma’s Approaches to Orphan Oncology Drug Approval Fuelling a Push for Reform By the FDA?

    May 1, 2018, 00:00

  • Degree of Agreement Between Randomized Controlled Trials and Observational Studies on Drug Effects- A Systematic Review

    May 1, 2018, 00:00

  • Choice Defines Qalys- A US Valuation of the EQ-5D-5L

    May 1, 2018, 00:00

  • Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR

    May 1, 2018, 00:00

  • Utilization Patterns Of The First US Biosimilar, Filgrastim-Sndz, Observed Between 2015 And 2017 In A Medical Transcription Database

    May 1, 2018, 00:00

  • Evolution of Regulatory Requirements for Retrospective Observational Studies Using Medical Records in Austria, Belgium, Italy, Netherlands and Switzerland

    May 1, 2018, 00:00

  • Pharmacoeconomic Assessment of Biological Therapy of Ulcerative Colitis

    May 1, 2018, 00:00

  • A Systematic Review of Clinical Efficacy Associated with use of Protease-Modulating Interventions with Diabetic Foot Ulcer or Venous Leg Ulcer

    May 1, 2018, 00:00

  • Secondary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Biologic Therapies for Treatment of Psoriatic Arthritis

    May 1, 2018, 00:00

  • The Frequency and Availability of Population-Specific Patient Reported Outcome Measures and Minimal Clinically Important Differences Among Approved Drugs in Canada

    May 1, 2018, 00:00

  • Profiles Of Non-Small Cell Lung Cancer Patients Treated With Immuno-Oncology Therapies In The United States And Western Europe

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Direct Medical Costs Among Adult Patients with Chronic Hepatitis C in China

    May 1, 2018, 00:00

  • Results of a Targeted Literature Review on the Cost-Effectiveness Models Developed for Retinopathy of Prematurity

    May 1, 2018, 00:00

  • An Analysis of Outpatient Healthcare Utilization and Costs in Children with Severe Mucopolysaccharidosis Type I in the United States

    May 1, 2018, 00:00

  • Emergency Department (ED) Utilization for Dental Or Oral Health Related Conditions (DOHRC) Before and after Implementation of Affordable Care Act (ACA)

    May 1, 2018, 00:00

  • Oncology Combination Pricing- Impact of Product Characteristics and Unmet Need

    May 1, 2018, 00:00

  • Medium Term Effect on Direct Medical Costs of Pediatric Pulmonary Hypertension Health Care with Specific Treatment in in Centro Medico Nacional 20 De Noviembre (Nmcissste, Mexico)

    May 1, 2018, 00:00

  • Financial Burden Over Time in Older Adults with Cancer, Heart Disease, or Diabetes

    May 1, 2018, 00:00

  • Evaluating and Valuing Drugs for Rare Conditions- No Easy Answers

    May 1, 2018, 00:00

  • Treatment Patterns Of Alk+ Non-Small Cell Lung Cancer Patients In The United States And Western Europe

    May 1, 2018, 00:00

  • The Elephant(S) in the Room – Aggrandizement of STA Guidance Workload for Nice

    May 1, 2018, 00:00

  • Treatment Patterns PSA

    May 1, 2018, 00:00

  • Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients- Analysis of the American Burn Association National Burn Repository

    May 1, 2018, 00:00

  • Clinical, Humanistic, and Economic Burden of Osteoarthritis (OA) Among Noninstitutionalized Adults in the United States (US)

    May 1, 2018, 00:00

  • Budget Impact Analysis with Simultaneous Multiple Market Entrants- Static Versus Dynamic Baseline Market Shares

    May 1, 2018, 00:00

  • Cost Effectiveness Of Direct Oral Anticoagulants (DOACS) Compared With Warfarin- A Literature Review

    May 1, 2018, 00:00

  • Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B- Standard half-Life Vs. Extended Half-Life Products

    May 1, 2018, 00:00

  • Feminine Hygiene Product Use and Awareness Among Young Us Adults

    May 1, 2018, 00:00

  • Prescription Pattern Of Opioids Among Prostate Cancer Patients Of Various Racial Groups

    May 1, 2018, 00:00

  • Real World Incidence and Prevalence of Systematic Lupus Erythematosus in Alberta, Canada

    May 1, 2018, 00:00

  • Real-World Comparison of Healthcare Costs Among Patients with Type 2 Diabetes Treated with Dulaglutide Vs. Liraglutide in the United States

    May 1, 2018, 00:00

  • Improved Quality Control With Subcutaneous (SC) Infusion Pump

    May 1, 2018, 00:00

  • Burden of Illness of Chronic Hepatitis C in Medicaid

    May 1, 2018, 00:00

  • Complications Related Health Utility Decrements for Type 2 Diabetes Population in the United States

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Commonly Used Biologic Drugs for the Treatment of Moderate-To-Severe Psoriasis in the United States

    May 1, 2018, 00:00

  • Using Real World Data to Establish An Optimal Treatment Target for HBA1C in Diabetes Type 2

    May 1, 2018, 00:00

  • Polypharmacy Use Among Patients with Diabetes- A Cross-Sectional Retrospective Study

    May 1, 2018, 00:00

  • Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commer ...

    May 1, 2018, 00:00

  • Do Us Payers Consider Cost-Effectiveness when Defining Prescription Benefits? A Study of Targeted Therapies for Rheumatoid Arthritis and Moderate-To-Severe Psoriasis

    May 1, 2018, 00:00

  • Armed Conflict and Infant Mortality Due to Diarrhea in Colombian Children

    May 1, 2018, 00:00

  • Disposable vs. Fiber Optic Reusable Bronchoscopes for High-Risk Procedures- Cost-Effectiveness Analysis (CEA)

    May 1, 2018, 00:00

  • Does Exposure to Health Valuation Tasks Impact One’s Self Rated Health?

    May 1, 2018, 00:00

  • Non-Inferiority Clinical Trial Design, Drug Approval, and Implications For Clinicians in Prescribing Oral Anticoagulants

    May 1, 2018, 00:00

  • Rate and Reimbursement of Ankle Screw Removal Procedures after Syndesmotic Fixation

    May 1, 2018, 00:00

  • Progressive Primary Multiple Sclerosis (PPMS)- Where Disability is Growing and Treatment is Absent

    May 1, 2018, 00:00

  • The Economic Impact of Shingles Vaccine Disparities Among Hispanics

    May 1, 2018, 00:00

  • Adverse Drug Reactions (ADRS) Associated with Medications used to Treat HIV/AIDS- 2001-Present

    May 1, 2018, 00:00

  • Utilization of a Precise, Clinically Relevant, Digital Classification System to Identify Variation in Care and Costs Among Patients with Breast Cancer

    May 1, 2018, 00:00

  • Alzheimer’s Attributable Costs in the United States- A Secondary Analysis of Medical Expenditure Panel Survey 2011-2015

    May 1, 2018, 00:00

  • Total Costs Distribution for Multiple Myeloma in Single Upper Middle Income Country- Is Cost Data Distribution Comparable with High Income Countries?

    May 1, 2018, 00:00

  • Economic Value Tool Evaluating Total Procedural Costs Associated with the Creation of Colorectal Anastomoses

    May 1, 2018, 00:00

  • Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective

    May 1, 2018, 00:00

  • Association Between Inhaled Corticosteroids and Pneumonia in Asthma Patients

    May 1, 2018, 00:00

  • Budget Impact Analysis of two Approved Therapies for Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00

  • Differences in the Flexibility of Muscles of Athletes Doing Weight Training and Functional Training

    May 1, 2018, 00:00

  • Budget Impact Analysis of Oritavancin for the Treatment of Moderate to Severe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) from a Hospital Perspective

    May 1, 2018, 00:00

  • The Cost Of Integrating Whole Genome Sequencing Into The Care Of Cardiomyopathy Patients- Sensitivity And Scenario Analyses

    May 1, 2018, 00:00

  • Comparing the Costs and Outcomes of a Twin Interlocking Derotation and Compression Screw Cephalomedullary Nail (2-Screw Nail)* with a Single Screw Cephalomedullary Nail (Single-Screw Nail) in Patients with Intertrochanteric HIP Fractures

    May 1, 2018, 00:00

  • A Systematic Literature Review of Methodology to Determine Treatment Persistence in Inflammation and Immunology Observational Database Studies

    May 1, 2018, 00:00

  • Association of Disease Modifying Antirheumatic Drugs (DMARD) and Tumor Necrosis Factor (TNF)- Alpha Inhibitor Therapy and Infection In Rheumatoid Arthritis Patients in a Medicaid Population

    May 1, 2018, 00:00

  • Real-World Treatment Patterns And Care Pathways In Metastatic Castration Resistant Prostate Cancer

    May 1, 2018, 00:00

  • Disease Burden and Integreted Disease Management of Biologic Treated Psoriasis Patients with Psoriatic Arthritis in Clinical Practi Results from Multicountry Study in EU5

    May 1, 2018, 00:00

  • Assessing Type and Impact of Biases Potentially Occurring when Analyzing Real World Eviden The Case of Second Line Treatment for Ovarian Cancer

    May 1, 2018, 00:00

  • Availability of Real-World Evidence (RWE) to Support Economic Modelling in Primary Progressive Multiple Sclerosis (PPMS)

    May 1, 2018, 00:00

  • Population Models Suppporting Decision Making on a Policy Level – A Systematic Review

    May 1, 2018, 00:00

  • Unmet Needs in the Management of Hypoactive Sexual Desire Disorder in Premenopausal Women

    May 1, 2018, 00:00

  • Inclusion of Drugs in a Formulary- A Case Study

    May 1, 2018, 00:00

  • Trends of Antibiotic Consumption in Intensive Care Units of Colombia, 2010-2016

    May 1, 2018, 00:00

  • Evaluating the Effect of The Change in ACC/AHA Blood Pressure Guidelines on The Prevalence of Diagnosed Hypertension

    May 1, 2018, 00:00

  • Do Medical Homes Affect Healthcare Utilization Rates? A Longitudinal Evaluation on Medical Home Implementation in Italy

    May 1, 2018, 00:00

  • Latest Insights on the Cost Efficiency of Therapeutic Plasma Exchange in Treating Guillain-Barre Syndrome

    May 1, 2018, 00:00

  • Epidemiology Of Hyperhidrosis in the United States- A Systematic Literature Review

    May 1, 2018, 00:00

  • Rifaximin and Eluxadoline Utilization for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the United States and Budget Impact Analysis of Switching from Eluxadoline to Rifaximin

    May 1, 2018, 00:00

  • Ultrafiltration vs. Diuretics for the treatment of Fluid Overload in Heart Failure Patients- A Hospital Cost Analysis

    May 1, 2018, 00:00

  • Risk of Diabetes Among Intensive and Moderate Dose Statin Users with Potential Modifying Effects of Treatment Duration

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis of Risperidone and Olanzapine in Schizophrenic Patients

    May 1, 2018, 00:00

  • Acute Healthcare Utilization Patterns Among People with Type 2 Diabetes Using Professional CGM in the United States

    May 1, 2018, 00:00

  • Consumer Preferences for Precision Medicine Technologies- Evidence from A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Market Access Challenges and Opportunities for Anti-Infectives- An EU5 Perspective

    May 1, 2018, 00:00

  • Out-of-Pocket Cost Burden and Price Elasticity of Demand for Ivacaftor use in Cystic Fibrosis

    May 1, 2018, 00:00

  • Globalization Module for A Diabetes Progression Prediction Model- The Building, Relating, Acting, and Validating Outcomes (Bravo) Model

    May 1, 2018, 00:00

  • Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Estimation of Total Burden of Bladder Cancer in Brazil – An Economic and Clinical Approach

    May 1, 2018, 00:00

  • Ventilator-Associated Pneumonia- Validity of Quality Metrics and Outcomes of Current Practices

    May 1, 2018, 00:00

  • Long-Term Benefits of Employee Wellness Programs- A Blue Cross Blue Shield of Louisiana (BCBSLA) Case Study

    May 1, 2018, 00:00

  • Deficit of the Hungarian Health Insurance Fund Between 1994-2014

    May 1, 2018, 00:00

  • Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device- Results of a Randomized Equivalence Trial

    May 1, 2018, 00:00

  • The Economic Burden of Varicella in Mexico

    May 1, 2018, 00:00

  • Simultaneous Development of Patient-Reported Outcome Measures for Masseter Muscle Hypertrophy in An Asia Population

    May 1, 2018, 00:00

  • A Review of Definition of Smoking Status When Using Electronic Medical/Health Records and Claims Databases In Studies

    May 1, 2018, 00:00

  • Efficacy and Safety of Vedolizumab in the Treatment of Ulcerative Colitis- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Drug Utilization Review of Acute Coronary Syndrome Patients in Hong Kong and United States

    May 1, 2018, 00:00

  • Racial Disparity in the Use of First-Line Psychosocial Care For Children and Adolescents Initiating Therapy on Antipsychotics

    May 1, 2018, 00:00

  • A Review of Patient-Reported Outcomes in Nonalcoholic Steatohepatitis (NASH)

    May 1, 2018, 00:00

  • Early Check- A Voluntary Newborn Screening Program and Research Registry to Facilitate Clinical Trials in Pre-Symptomatic Infants with Rare Diseases

    May 1, 2018, 00:00

  • Cost-Benefitanalysis of Hepatitis B Vaccination Strategies for Preventing Mother-to-Child Transmission：A Decision Tree-Markov Model

    May 1, 2018, 00:00

  • Cost-Effectiveness of Transcathether Aortic Valve Implantation with the New Repositionable Self-Expandable Evolut R Versus Corevalve System in Inoperable Patients with Severe Aortic Stenosis in Mexico

    May 1, 2018, 00:00

  • Copyright/Subscription

    May 1, 2018, 00:00

  • Evaluation of Modified Item Characteristics on Item Comprehension and Psychometric Performance

    May 1, 2018, 00:00

  • A Systematic Review and Network Meta-Analysis of Panitumumab with Chemotherapy in the First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer (MCRC) with Left-Sided Tumors

    May 1, 2018, 00:00

  • Validation of a Claims-Based Algorithm for Identification of Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the US

    May 1, 2018, 00:00

  • Extended Thromboprophylaxis With Betrixaban Is Cost-Effective In Acutely ILL Medical Patients

    May 1, 2018, 00:00

  • Reimbursement Decision-Making in Ukraine- Current and Future Directions

    May 1, 2018, 00:00

  • Comparative Effectiveness Analysis Using Real World Evidence (RWE) and Applying a Causal Marginal Structural Model- the Case of Second-Line Treatment in Patients with Ovarian Cancer

    May 1, 2018, 00:00

  • Parent and Adult Patient Attitudes About Gene Therapy as a Therapeutic Option for Duchenne Muscular Dystrophy

    May 1, 2018, 00:00

  • Budget Impact Analysis For Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Costa Rica

    May 1, 2018, 00:00

  • Challenges in Outlier Surgeon Assessment in the Era of Public Reporting

    May 1, 2018, 00:00

  • Identifying Priority Regions for Improving Treatment Options for Illicit Drug Dependence

    May 1, 2018, 00:00

  • Demographic Variation of Hepatitis C Virus (HCV) Prevalence in the US- Results from the National Health and Nutrition Examination Survey 2009 – 2016

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sequential Treatment Strategies with Tnf-Inhibitors in Patients with Ankylosing Spondylitis- A Patient-Level Simulation Model

    May 1, 2018, 00:00

  • Effect of Patient Involvement in Treatment Decision Making on Disease Outcomes in Rheumatoid Arthritis in the EU5

    May 1, 2018, 00:00

  • Characteristics and Rate of Subsequent Lumbar Spine Fusion Surgery Among Patients Treated with Allogenic Cellular Bone Matrix for Posterior Lumbar Spinal Fusion

    May 1, 2018, 00:00

  • Perceptions of Cost Pressure Associated with Biosimilars Among Physicians in Europe

    May 1, 2018, 00:00

  • Measuring the Extent and Impact of Disease Sub-Specialization Among Neurologists in the US

    May 1, 2018, 00:00

  • Creating a Flexible Continuous Procedure Distribution Model Based on Pre-Test Risk Level for Lung Cancer in Patients with Incidentally Detected Pulmonary Nodules

    May 1, 2018, 00:00

  • A Value Of Information (VOI) Analysis Of Evolocumab For The Prevention Of Cardiovascular Deaths And Incidences In Secondary Prevention Patients

    May 1, 2018, 00:00

  • Adherence and Persistence with Antiplatelet Agents in Patients with New Episode of Acute Coronary Syndrome in Tianjin, China

    May 1, 2018, 00:00

  • Testosterone Replacement Therapy Reduces Cardiovascular Events in Men with Chronic Kidney Disease

    May 1, 2018, 00:00

  • Resource Use Related to Pediatric Lower Limb Spasticity in Canada- Physician Questionnaire

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Bronchial Thermoplasty Versus Pharmacological Therapies in Patients with Severe Asthma in Mexico, Colombia and Spain

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Nilotinib Versus High-Dose Imatinib for the Second-Line Treatment of Chronic Myeloid Leukemia In China - Based on Nation-Wide Data

    May 1, 2018, 00:00

  • Effectiveness of the Treatment with New Antivirals in Adult Patients with Chronic Infection with Hepatitis C Virus in Colombia During 2016-2017

    May 1, 2018, 00:00

  • Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)

    May 1, 2018, 00:00

  • Chi-Square Automatic Interaction Detection (CHAID) Analysis- Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy

    May 1, 2018, 00:00

  • Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer (NSCLC) in the United States

    May 1, 2018, 00:00

  • Interseizure Interval In Frequently Admitted Epilepsy Patients

    May 1, 2018, 00:00

  • Small Changes, Big Differences? Cohort Variation by Parameter Specifications in Claims-Based Drug use Evaluations

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia

    May 1, 2018, 00:00

  • Opioid Use Among Patients Presenting with Migraine in the Emergency Department

    May 1, 2018, 00:00

  • Perceived Cancer Risk and Evaluation of Public Awareness of Direct-to-Consumer Genetic Tests in the United States

    May 1, 2018, 00:00

  • Anti-Vegf Dosing Intervals in Patients with Neovascular Age-Related Macular Degeneration- a Retrospective Cohort Study in Australia

    May 1, 2018, 00:00

  • Demonstration of Ngram Frequency and Cluster Method for Identifying Signals of Transfusion Reactions (TR)

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis of Intra-Articular Triamcinolone Acetonide Extended-Release Injectable Suspension (TA-ER) Versus Triamcinolone Acetonide Crystalline Suspension For Symptomatic Knee Osteoarthritis

    May 1, 2018, 00:00

  • Cost-Effectiveness and Return on Investment of Continuous Lateral Rotation Therapy to Prevent Ventilator-Associated Pneumonia and Pressure Injuries in the Critical Care Setting

    May 1, 2018, 00:00

  • Cost-Effectiveness of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Payer Perspective

    May 1, 2018, 00:00

  • Characterizing the Clinical and Economic Burden of Type 2 Diabetes (T2DM) Patients on Multiple Daily Injections (MDI) of Insulin- A Systematic Literature Review

    May 1, 2018, 00:00

  • Hepatitis C Patient Characteristics Across Antiviral Treatment Eras in a Large Managed Care Organization

    May 1, 2018, 00:00

  • Growth of Hospital-Owned Specialty Pharmacies- Importance and Implications for Manufacturer Channel and Patient Access Strategies

    May 1, 2018, 00:00

  • Cost - Effectiveness Analysis of Ultrasound Screening for Thyroid Cancer in Asymptomatic Population

    May 1, 2018, 00:00

  • Psychometric Validation of the 1-Month Recall Uterine Fibroid Symptom and Health-Related Quality-of-Life Questionnaire

    May 1, 2018, 00:00

  • Association Between Exenatide/Β2AR Use and Parkinson’s Disease Risk in Medicare Population

    May 1, 2018, 00:00

  • Budget Impact Analysis of the Advance Lubricath® Foley Catheter Tray® for Urinary Catheterization of Long Duration in Mexico

    May 1, 2018, 00:00

  • Patient and Provider Characteristics Associated with PHQ-9 Administration and Outcomes Assessment in Routine Clinical Practi Findings from the OM1 Data Cloud

    May 1, 2018, 00:00

  • Changes in Healthcare Resource use and Costs Associated with the use of Adjunctive Atypical Antipsychotics In Major Depressive Disorder

    May 1, 2018, 00:00

  • Age-Related Hospital Utilization Among Patients with Marfan Syndrome

    May 1, 2018, 00:00

  • Predictive Model Directed Interventions Improve Medication Adherence Program Efficiency

    May 1, 2018, 00:00

  • New Estimates of the Willingness-to-Pay for a Statistical Life Year- A Systematic Review of the Empirical Economic Literature

    May 1, 2018, 00:00

  • Adherence Issues in COPD- How Can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00

  • Cost-Effectiveness of Cetuximab for Left-Side Metastatic Colorectal Cancer in Ecuador

    May 1, 2018, 00:00

  • Time for Reimbursement for Orphan Drugs in EU5

    May 1, 2018, 00:00

  • Developing Content for a New Generic Qaly Measure- Results from a Qualitative Literature Review (E-Qaly Project)

    May 1, 2018, 00:00

  • Factors Associated with Data Collection Duration and Participation Rates in Retrospective Noninterventional Medical Record Review Studies

    May 1, 2018, 00:00

  • Comparing Outcomes Between Fixed and Flexible Treatment Intervals with Botulinum Neurotoxins Type A in the Management Of Blepharospasm and Cervical Dystonia – A Cost-Effectiveness Analysis from the Romanian Perspective

    May 1, 2018, 00:00

  • Real-World Treatment Patterns For Patients With Head And Neck Squamous Cell Carcinoma (HNSCC) Treated With Immuno-Oncology (IO) Therapy

    May 1, 2018, 00:00

  • The Role of General Practitioners During Economic Crises

    May 1, 2018, 00:00

  • Effect of Cash Prescriptions on Statin, Antihypertensive, And Antidiabetic Medication Adherence Estimates in the Commercially-Insured Population

    May 1, 2018, 00:00

  • Short-Term Cost-Effectiveness of Glucagon-Like Peptide-1 Receptor Analogues Versus Sodium-Glucose Cotransporter-2 Inhibitors as Second-Line Add-On Therapy for Type 2 Diabetes in the United States

    May 1, 2018, 00:00

  • Converting Eortc QLQ-C30 Scores To EQ-5D Utility Scores in the Brigatinib Alta Study

    May 1, 2018, 00:00

  • Use of Anti-Diabetic Medication is Not Associated with Cancer Risk in Chinese Patients with Type 2 Diabetes

    May 1, 2018, 00:00

  • Budget Impact Analysis of Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00

  • Evaluation of Antihyperglycemic Medication Cessation As An Acceptable Proxy for Glycemic Control after Bariatric Surgery

    May 1, 2018, 00:00

  • Economic Evaluation of Enterex® IMX, A Specialized Nutrition Supplement Containing Arginine, in the Treatment of Neurocritical Patients in México

    May 1, 2018, 00:00

  • Pneumococcal Vaccines Produce Substantial Cost-Savings in Mexico

    May 1, 2018, 00:00

  • Medication Usage, Length of Stay, and Hospital Charges in Bipolar Disorder Patients- A Retrospective Analysis of a Large Us Electronic Health Record Database

    May 1, 2018, 00:00

  • Cost Estimation of Pharmacy Services and the Recommendation of New Charge Items in Hospitals of Southwest China

    May 1, 2018, 00:00

  • Updated New Drugs Approval Timing in Italy (2015-2017)

    May 1, 2018, 00:00

  • Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00

  • Reviewing Adverse Drug Event Reporting Between Randomized Clinical Trial Data and Real World Post Market Data for Sorafenib and Sunitinib

    May 1, 2018, 00:00

  • Economic Evaluation of the Nerve Conduction Measuring Device for the Diagnosis of Peripheal Diabetic Neuropathy

    May 1, 2018, 00:00

  • Identifying Community-Reported Health Priorities Using Free Listing Interviews in a Mixed Methods Approach

    May 1, 2018, 00:00

  • Adherence Issues in Osteoarthritis- How can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00

  • Comparison of Healthcare Resource Utilization and Clinical Status Among Type 2 Diabetes Patients Using Multiple-Daily Injection (MDI) Insulin Therapy Versus Non-Mdi Therapy

    May 1, 2018, 00:00

  • Economic Impact of Diabetes Self-Management Education

    May 1, 2018, 00:00

  • Hypoactive Sexual Desire Disorder (HSDD) is not “The Female Erectile Dysfunction (ED)”- Challenges with the Characterization of HSDD in Women

    May 1, 2018, 00:00

  • Evaluating A Conceptual Platform for Facilitating and Scaling Pharmaceutical Risk Sharing Arrangements

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Costs Among Commercially Insured Patients with Juvenile Idiopathic Arthritis (JIA) in the United States

    May 1, 2018, 00:00

  • Revealed Preference for Additional Healthcare Spend and the Institute for Clinical and Economic Review's (ICER) Budget Impact Threshold

    May 1, 2018, 00:00

  • A Predictive Modeling Approach that Accurately Identifies Members with the Likelihood of Having a Future Costly Event

    May 1, 2018, 00:00

  • How Health Technology Assessment Programs Take Into Account the Patient Perspective in Healthcare Decision Making- Comparison Between the United States and Several European Countries

    May 1, 2018, 00:00

  • Readiness of Community Oncology and Urology Practices for Value-Based Care

    May 1, 2018, 00:00

  • Femoral Shaft Fractures- Treatment Costs and Complication Risks – A Claims Database Analysis

    May 1, 2018, 00:00

  • Efficacy and Safety Analysis of Radium-223 in Patients with Prostate Cancer Castration-Resistant and Bone Metastasis

    May 1, 2018, 00:00

  • Medical Expenditures for Patients with Pulmonary Embolism Among the Population with Urban Basic Health Insurance in China

    May 1, 2018, 00:00

  • Cost - Effectiveness of the use of the Insulin Pump Therapy Versus Daily Multiple Injections in Patients with Type 1 Diabetes at the Mexican Institute of Social Security

    May 1, 2018, 00:00

  • The use of Historical Trial Data to Inform Extrapolations of Immature Survival Data within a Bayesian Framework in Comparison to Standard Approaches

    May 1, 2018, 00:00

  • Regular Physical Activity- Impact on Health Care Utilization Patterns and Expenses in a Cohort of Overweight and Obese US Adults with Diabetes

    May 1, 2018, 00:00

  • Is Self-Rated Health of Americans Different in 2017 Compared to 2002?

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hereditary Angioedema- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Burden of Illness in Ostomates- A German-Based Claims Database Analysis

    May 1, 2018, 00:00

  • Exploring Cost Savings of a Modified Plerixafor Protocol for Use in Autologous Stem Collection

    May 1, 2018, 00:00

  • Resource use of Patients Diagnosed with Schizophrenia- Analysis of Physician Record form Data in the United States

    May 1, 2018, 00:00

  • Economic Impact of Treatment Adherence in Exocrine Pancreatic Insufficiency (EPI) Patients Treated with Pancreatic Enzyme Replacement Therapy (PERT)

    May 1, 2018, 00:00

  • Estimating Patient Utility in Migraine- Longitudinal Analysis of Erenumab Clinical Trial Data

    May 1, 2018, 00:00

  • Economic Impact of Generic Antiretrovirals in France for HIV Patient’s Care- A Simulation Between 2018 and 2022

    May 1, 2018, 00:00

  • Treatment Patterns and Medicaid Spending in Comorbid Schizophrenia Populations- Once-Monthly Paliperidone Palmitate Vs Oral Atypical Antipsychotics

    May 1, 2018, 00:00

  • Tumor Necrosis Factor Inhibitor Therapy and The Risk of Developing Depression Among Working-Age Adults with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Prevalence of Pneumococcal Vaccination in a Recently Resettled Refugee Population

    May 1, 2018, 00:00

  • Assessing the Trends in the use of Fluoroquinolones Before and after FDA Notice of its Restricted use in Uncomplicated Infections

    May 1, 2018, 00:00

  • Comparative Efficacy of Consolidation Therapy After Chemoradiation Therapy (CRT) in Patients with Unresectable, Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)- A Network Meta-Analysis

    May 1, 2018, 00:00

  • A Comparison Of Patient Level Data (IPD) Regression Techniques In Adjusting For Cross Trial Differences In An Indirect Treatment Comparison (ITC)- A Worked Example Of Simulated Treatment Comparison (STC) Vs Bayesian Ipd Regression

    May 1, 2018, 00:00

  • Attitude of Healthcare Professionals Towards Understanding the Issue of Antimicrobial Resistance

    May 1, 2018, 00:00

  • Treatment Patterns and Costs of Care in Commercially-Insured and Medicaid Patients with Transfusion-Dependent SS-Thalassemia

    May 1, 2018, 00:00

  • Prescription Drug Coverage for Treatment of Low Back Pain Among U.S. Medicaid, Medicare Advantage and Commercial Insurers

    May 1, 2018, 00:00

  • Evaluation of Current And Future PD-(L)1 Testing Requirements in the US

    May 1, 2018, 00:00

  • The Influencing of Hospitalization Costs Through Length of Stay Among Inpatients with Positive Antimicrobial Susceptibility Based on the Method of Structural Equation Model

    May 1, 2018, 00:00

  • What US Healthcare Providers Value in Genomic Precision Medicine- A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Challenges in Translating the Sheehan Suicidality Tracking Scale (Updated Adult Version)

    May 1, 2018, 00:00

  • Editorial Board

    May 1, 2018, 00:00

  • Value-Based Care In Oncology- Challenges And Barriers Amongst Community Oncologists

    May 1, 2018, 00:00

  • Implantable Cardiac Monitor Compared with Conventional Diagnostic for Unexplained Syncope- A Combined Cost-Effectiveness and Budget-Impact Analysis

    May 1, 2018, 00:00

  • Poor Medication Adherence and High Rates of Treatment Discontinuation Among SCD Patients Treated with Hydroxyurea

    May 1, 2018, 00:00

  • Relative Clinical and Economic Burden of Community Acquired Pneumonia in the Elderly

    May 1, 2018, 00:00

  • Biosimilar Market Access – Comparing the US and European Markets

    May 1, 2018, 00:00

  • Real World Incidence and Prevalence of Low Back Pain- A Systematic Review

    May 1, 2018, 00:00

  • Hospital Related Clinical and Economical Outcomes of a Bicruciate Knee System in Total Knee Arthroplasty Patients

    May 1, 2018, 00:00

  • New Oral Anticoagulants And The Risk Of Vasculitis- A Nested Case-Control Study

    May 1, 2018, 00:00

  • United States Health Plan Cancer Concerns In 2018

    May 1, 2018, 00:00

  • Market Access for Advanced Therapy Medicinal Products (ATMPS) Begins at the Bench

    May 1, 2018, 00:00

  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Peru

    May 1, 2018, 00:00

  • Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

    May 1, 2018, 00:00

  • Mapping the Gaps- Gender Differences in Preventive Cardiovascular Care Among Managed Care Members In Four Metropolitan Areas

    May 1, 2018, 00:00

  • Infant Mortality from Acute Respiratory Infections and Armed Conflict- An Exploratory Analysis

    May 1, 2018, 00:00

  • Impact Of Dining Out And Food Intake Pattern On Atrial Fibrillation Prevalence In Hong Kong Chinese Elders

    May 1, 2018, 00:00

  • Patient Characteristics And Treatment Patterns From Spear-Bladder- Study Informing Treatment Pathway Decision In Bladder Cancer

    May 1, 2018, 00:00

  • Temporal Trends in Treatment of Type 2 Diabetes Mellitus, 2007-2014

    May 1, 2018, 00:00

  • Patterns of Treatment and Recurrence In Patients with Non-Metastatic Melanoma WHO Underwent Lymph Node Dissection Surgery

    May 1, 2018, 00:00

  • Using Machine Learning to Predict Opioid Overdoses Among Prescription Opioid Users

    May 1, 2018, 00:00

  • Utilization, Spending, and Prices Trends for Anti-Epileptic Drugs (AEDS) in the U.S. Medicaid Programs- Empirical Data Analysis from 2010 to 2016

    May 1, 2018, 00:00

  • Productivity Losses Among Patients with Migraine- An Analysis of Erenumab Clinical Trial Data

    May 1, 2018, 00:00

  • Prevalence of Anxiety Symptoms and its Correlates Among Medical Students in China- A National Survey in 33 Universities

    May 1, 2018, 00:00

  • Humanistic And Economic Burden Associated With Anxiety And Depression Among Adults With Diabetes And Hypertension

    May 1, 2018, 00:00

  • What Is The Future Of Indication-Based Pricing And Contracting (IBPC) For Market Access Of New Oncologic And Biologic Agents In Major Global Markets?

    May 1, 2018, 00:00

  • Trends and Risk Factors Associated with Severe Maternal Morbidity in Texas Women

    May 1, 2018, 00:00

  • A Tale of Two Universal Health Insurance Schemes in One Country- Horizontal Inequality of Government Medical and Pharmaceutical Benefits for Australian Children

    May 1, 2018, 00:00

  • Access to Patient-Centered Medical Home Care Among Adults with Chronic Conditions- Findings from the Medical Expenditures Panel Survey

    May 1, 2018, 00:00

  • Trends in Prescription Opioid Use Among Hemodialysis Patients in the United States, 2007-2014

    May 1, 2018, 00:00

  • Global Growth in Public Healthcare- Emerging Markets Take the Wheel

    May 1, 2018, 00:00

  • Systematic Review of Diagnosis and Treatment of Obesity and Bing- Eating Syndrome

    May 1, 2018, 00:00

  • Lifetime Cost-Effectiveness of Adjuvant External Beam Whole Breast Irradiation (EBWBI) in Estrogen Receptor Positive (ER+) Early-Stage Breast Cancer (ESBC) Women- Cardiotoxicity Consideration

    May 1, 2018, 00:00

  • The Effect of Generic Statin Availability on Initial Statin Prescribing Trends Among Medicare Beneficiaries

    May 1, 2018, 00:00

  • Utilization And Impact Of Value Assessment Frameworks On Payer Decisions Regarding Chimeric Antigen Receptor T-Cell Therapies

    May 1, 2018, 00:00

  • The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management

    May 1, 2018, 00:00

  • Costs Related to Infusion Therapy Room and Staff for Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00

  • Comparing Cost-Per-Qalys Gained And Cost-Per-Dalys Averted Analyses

    May 1, 2018, 00:00

  • Evaluation On Use Of Digital Refill Reminders On Patient Adherence To Antiretroviral Medications

    May 1, 2018, 00:00

  • Non-Adherence to Antipsychotics and Disease Comorbidity- A Double Whammy in Schizophrenia Management

    May 1, 2018, 00:00

  • Emergent Therapies And Egfr Mutation Testing In Non-Small Cell Lung Cancer- Real-World Practices

    May 1, 2018, 00:00

  • Real World Experience with Calcipotriene and Betamethasone Dipropionate Foam 0.005%/0.064% (Cal/BD Foam) in the Treatment of Adult Psoriasis Including Psoriasis Itch from Retrospective Chart Review

    May 1, 2018, 00:00

  • Evaluation of Electronic Health Record Data Quality to Assess the Clinical Indices of Anemia in Dialysis Patients

    May 1, 2018, 00:00

  • Serum Autoantibodies Multi-Testing in Rheumatoid Arthritis in Primary Care can Reduce Avoidable Costs Associated to False Positives. A Simulation Study in the United States of America

    May 1, 2018, 00:00

  • Budget Impact Model of Low Chloride Balanced Intravenous Solutions in Patients with Systemic Inflammatory Response Syndrome from a Hospital Perspective in Colombia

    May 1, 2018, 00:00

  • New Drugs Approval in Italy- Updated Analysis of the Applied Negotiation Conditions 2015-2017

    May 1, 2018, 00:00

  • An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer

    May 1, 2018, 00:00

  • Valuing Health-Related Quality of Life for Inpatients with Diabetes-Related Complications In China

    May 1, 2018, 00:00

  • Management of Biosimilars- Key Considerations for Pharmacists in Patient Care

    May 1, 2018, 00:00

  • Statins Adherence And Its Risk Factors Analysis in Chinese Ascvd Patients Based on A Provincial Claim Data

    May 1, 2018, 00:00

  • Real World Practice and Patient-Reported Outcomes of Uncontrolled Hypertensive Patients In Korea

    May 1, 2018, 00:00

  • Inpatient Admission Length Of Stay And Costs Among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared To Patients Receiving Surgical Cutdown For Closure Of Large Bore Arterial Access

    May 1, 2018, 00:00

  • Selecting Health States for EQ-5D-3L Valuation Studies- Statistical Considerations Matter

    Apr 1, 2018, 00:00

  • Editorial Board

    Apr 1, 2018, 00:00

  • A Framework for Measuring Low-Value Care

    Apr 1, 2018, 00:00

  • Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV- A Systematic Literature Review

    Apr 1, 2018, 00:00

  • Sustained 3-Year Benefits in Quality of Life After Percutaneous Coronary Interventions in the Elderly- A Prospective Cohort Study

    Apr 1, 2018, 00:00

  • Table of Contents

    Apr 1, 2018, 00:00

  • Utility-Based Instruments for People with Dementia- A Systematic Review and Meta-Regression Analysis

    Apr 1, 2018, 00:00

  • Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

    Apr 1, 2018, 00:00

  • The CDI-DaySyms- Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection

    Apr 1, 2018, 00:00

  • Copyright/Subscription

    Apr 1, 2018, 00:00

  • Modeling Clinical Outcomes in Prostate Cancer- Application and Validation of the Discrete Event Simulation Approach

    Apr 1, 2018, 00:00

  • Are US Health Insurers Efficient or Not?

    Apr 1, 2018, 00:00

  • The Use of MCDA in HTA- Great Potential, but More Effort Needed

    Apr 1, 2018, 00:00

  • Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population

    Apr 1, 2018, 00:00

  • A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures

    Apr 1, 2018, 00:00

  • Emerging Good Practices for Transforming Value Assessment- Patients’ Voices, Patients’ Values

    Apr 1, 2018, 00:00

  • What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

    Apr 1, 2018, 00:00

  • Improving Value for Patients with Eczema

    Apr 1, 2018, 00:00

  • The Value Challenge- Examining the Transformative Strategies to Measure or Evaluate the Value of Health Care Interventions

    Apr 1, 2018, 00:00

  • Comparing 15D Valuation Studies in Norway and Finland—Challenges When Combining Information from Several Valuation Tasks

    Apr 1, 2018, 00:00

  • Sensitivity of Claims-Based Algorithms to Ascertain Smoking Status More Than Doubled with Meaningful Use

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance

    Mar 1, 2018, 00:00

  • Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease

    Mar 1, 2018, 00:00

  • Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients

    Mar 1, 2018, 00:00

  • Table of Contents

    Mar 1, 2018, 00:00

  • What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY?

    Mar 1, 2018, 00:00

  • Paying for Cures- Perspectives on Solutions to the “Affordability Issue”

    Mar 1, 2018, 00:00

  • The ICER Value Framework- Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value

    Mar 1, 2018, 00:00

  • Resource Use and Cost of Alzheimer’s Disease in France- 18-Month Results from the GERAS Observational Study

    Mar 1, 2018, 00:00

  • Copyright/Subscription

    Mar 1, 2018, 00:00

  • Resolving the “Cost-Effective but Unaffordable” Paradox- Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts

    Mar 1, 2018, 00:00

  • Affordability of New Technologies- The Next Frontier

    Mar 1, 2018, 00:00

  • Affordability Challenges to Value-Based Pricing- Mass Diseases, Orphan Diseases, and Cures

    Mar 1, 2018, 00:00

  • Affordability of Health Care- A Global Crisis

    Mar 1, 2018, 00:00

  • The Importance of Model Structure in the Cost-Effectiveness Analysis of Primary Care Interventions for the Management of Hypertension

    Mar 1, 2018, 00:00

  • Editorial Board

    Mar 1, 2018, 00:00

  • Real-World Evidence- Useful in the Real World of US Payer Decision Making? How? When? And What Studies?

    Mar 1, 2018, 00:00

  • Estimating the Learning Curve of a Novel Medical Device- Bipolar Sealer Use in Unilateral Total Knee Arthroplasties

    Mar 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

    Feb 1, 2018, 00:00

  • A Comparison of Different Approaches for Costing Medication Use in an Economic Evaluation

    Feb 1, 2018, 00:00

  • The Impact of Decision Makers’ Constraints on the Outcome of Value of Information Analysis

    Feb 1, 2018, 00:00

  • Defining Elements of Value in Health Care—A Health Economics Approach- An ISPOR Special Task Force Report [3]

    Feb 1, 2018, 00:00

  • Editorial Board

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- A Missed Opportunity for ISPOR and Patients

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Frameworks- Serving the Needs of Decision Making

    Feb 1, 2018, 00:00

  • Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

    Feb 1, 2018, 00:00

  • Investigating the Heterogeneity in Women’s Preferences for Breast Screening- Does the Communication of Risk Matter?

    Feb 1, 2018, 00:00

  • Choice Defines Value- A Predictive Modeling Competition in Health Preference Research

    Feb 1, 2018, 00:00

  • Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease

    Feb 1, 2018, 00:00

  • Review of Recent US Value Frameworks—A Health Economics Approach- An ISPOR Special Task Force Report [6]

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Introduction- An ISPOR Special Task Force Report [1]

    Feb 1, 2018, 00:00

  • Copyright/Subscription

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Feb 1, 2018, 00:00

  • Table of Contents

    Feb 1, 2018, 00:00

  • Corrections to ’Systematic Literature Review and Indirect Treatment Comparison of the Efficacy of Semaglutide versus Empagliflozin as Add-On to Basal Insulin (PDB4)’

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- Seeking a Role for Health Economics

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- An Industry Perspective

    Feb 1, 2018, 00:00

  • An Overview of Value, Perspective, and Decision Context—A Health Economics Approach- An ISPOR Special Task Force Report [2]

    Feb 1, 2018, 00:00

  • Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach- An ISPOR Special Task Force Report [4]

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- The Use of Cost-Effectiveness Research in Decision Making among US Insurers

    Feb 1, 2018, 00:00

  • Corrections to ‘Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0’ [JVAL 20/8 (2017) 1009–1022]

    Feb 1, 2018, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Systematic Review and Network Meta-Analysis

    Feb 1, 2018, 00:00

  • Approaches to Aggregation and Decision Making—A Health Economics Approach- An ISPOR Special Task Force Report [5]

    Feb 1, 2018, 00:00

  • Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

    Jan 1, 2018, 00:00

  • Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices- An Application for Eliciting Patient Preferences for Diabetes Treatments

    Jan 1, 2018, 00:00

  • Accounting for Uncertainty in Decision Analytic Models Using Rank Preserving Structural Failure Time Modeling- Application to Parametric Survival Models

    Jan 1, 2018, 00:00
  • «
  • 61 (current)
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »